We are live on ! Find out more
PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

1 hedge funds and large institutions have $308K invested in Poseida Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 113 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 115 → 1 (-114)

100% less capital invested

Capital invested by funds: $519M → $308K (-$519M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 113

Holders
1
Holders Change
-114
Holders Change %
-99.13%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
113
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$96.1M
2
PCM
Pentwater Capital Management
Florida
-$82.8M
3
BlackRock
BlackRock
New York
-$54.1M
4
Nomura Holdings
Nomura Holdings
Japan
-$49.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$36.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
101
Amalgamated Bank
New York
– -$22K -2,291 Closed
SCM
102
Sterling Capital Management
North Carolina
– -$15.3K -1,592 Closed
SS
103
SBI Securities
Japan
– -$12.7K -1,327 Closed
FIA
104
FNY Investment Advisers
New York
– -$11K -1,200 Closed
Lazard Asset Management
105
Lazard Asset Management
New York
– -$7K -797 Closed
SAM
106
Smartleaf Asset Management
Massachusetts
– -$7.37K -777 Closed
Bessemer Group
107
Bessemer Group
New Jersey
– -$4K -425 Closed
Nisa Investment Advisors
108
Nisa Investment Advisors
Missouri
– -$3.16K -329 Closed
Carson Wealth (CWM LLC)
109
Carson Wealth (CWM LLC)
Nebraska
– -$2K -179 Closed
FFA
110
Farther Finance Advisors
California
– -$768 -80 Closed
CIAM
111
Caitong International Asset Management
Hong Kong
– -$720 -75 Closed
LC
112
Lindbrook Capital
California
– -$499 -52 Closed
GI
113
GAMMA Investing
California
– -$403 -42 Closed
US Bancorp
114
US Bancorp
Minnesota
– -$250 -26 Closed
Osaic Holdings
115
Osaic Holdings
Arizona
– -$10 -1 Closed
1 2 3 4
5

PSTX Hedge Fund Activity: Q1 2025 in Review

1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Poseida Therapeutics, Inc. Common Stock (PSTX) for Q1 2025, worth a combined $308K — down 100% from $519M a quarter earlier.

Sellers outnumbered buyers: 113 funds closed out of PSTX and 0 opened new positions — a net loss of 113 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $96.1M sold.

  • 1 institutional investor held Poseida Therapeutics, Inc. Common Stock (PSTX) as of Q1 2025, down from 115 in Q4 2024.
  • Funds reported $308K of Poseida Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Poseida Therapeutics, Inc. Common Stock positions in Q1 2025 and 113 closed out, a net change of -113 holders.
  • The largest Poseida Therapeutics, Inc. Common Stock seller in Q1 2025 was Fidelity Investments, an estimated $96.1M sold.

Based on aggregated 13F filings for Q1 2025.